share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann

Recursion Pharmaceuticals | 4:持股變動聲明-董事 Burrell Terry-Ann
美股sec公告 ·  06/05 18:17
Moomoo AI 已提取核心訊息
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following this transaction, Burrell's direct holdings in the company increased to a total of 69,411 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
Terry-Ann Burrell, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on June 3, 2024. The transaction involved a grant of 13,097 shares of Class A Common Stock at no cost. Following this transaction, Burrell's direct holdings in the company increased to a total of 69,411 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing commitment to align the interests of its employees with those of shareholders.
與Recursion Pharmaceuticals,Inc. [RXRX]相關的Terry-Ann Burrell於2024年6月3日完成了股票收購。 該交易涉及授予13,097股A類普通股,不涉及任何費用。 在此交易之後,Burrell在該公司的直接持股增加到69,411股。 該授予是公司股票報酬計劃的一部分,體現了與股東的利益相結合的員工持續承諾。
與Recursion Pharmaceuticals,Inc. [RXRX]相關的Terry-Ann Burrell於2024年6月3日完成了股票收購。 該交易涉及授予13,097股A類普通股,不涉及任何費用。 在此交易之後,Burrell在該公司的直接持股增加到69,411股。 該授予是公司股票報酬計劃的一部分,體現了與股東的利益相結合的員工持續承諾。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息